Skip to main content
. 2019 Apr 11;14:835–852. doi: 10.2147/COPD.S187661

Table S2.

Comparison of measurements between groups

Soluble protein markers Healthy Stable COPD P-value
IL1βb 22.1 (13.3, 27.7) 25.8 (4.8, 101.9) 0.690
IL5b 1.3 (0.2, 4.7) 6.1 (0.8, 10.1) 0.153
IL6b 102.1 (21.9, 168.6) 381.8 (57.1, 797.5) 0.075
IL8b 1,171.2 (863.2, 1,445.0) 1,302.6 (906.3, 1,721.0) 0.463
IL10b 0.2 (0.0, 0.7) 0.6 (0.1, 2.2) 0.094
IL13b 0.6 (0.3, 1.0) 0.4 (0.1, 1.0) 0.850
IL33b 0.6 (0.0, 5.3) 2.9 (0.0, 14.4) 0.351
sRAGEb 339.6 (195.1, 3,188.6) 473.0 (16.4, 1,043.1) 0.201
TNFαb 28.9 (0.0, 44.4) 26.7 (0.0, 104.0) 0.680
VEGFb 2,549.7 (2,326.0, 3,093.1) 2,371.8 (1,574.1, 3,308.6) 0.438
IgG autoantibodies
Aggrecanb 531.1 (474.3, 812.0) 569.6 (503.4, 622.5) 0.863
Amyloidb 86.7 (56.0, 95.2) 81.8 (38.4, 136.0) 0.825
CENP-Bb 3,994.0 (2,907.8, 4,956.0) 2,847.6 (2,430.3, 3,878.2) 0.099
Collagen Ia 356.8 (200.4, 513.2) 288.1 (243.9, 332.4) 0.357
Collagen IIb 408.4 (293.6, 1,000.9) 263.6 (211.7, 536.9) 0.073
Collagen IVb 149.9 (41.2, 658.3) 104.8 (48.1, 172.6) 0.363
Cytochrome Cb 665.9 (566.8, 763.6) 902.0 (697.4, 1,028.0) 0.008
Cytokeratin 18b 843.0 (278.0, 2,817.3) 945.3 (508.9, 1,932.7) 0.712
Elastinb 706.2 (661.3, 809.3) 742.3 (546.5, 869.0) 0.863
HSP47b 274.3 (166.0, 585.9) 206.0 (108.2, 645.3) 0.712
HSP70b 5,640.2 (4,735.5, 7,712.8) 5,016.0 (4,255.8, 5,498.5) 0.176
SS-Bb 3,771.4 (3,562.4, 4,298.6) 4,411.1 (3,419.8, 5,113.1) 0.228
Vimentinb 295.8 (284.3, 574.1) 301.6 (221.5, 474.8) 0.313
IgM autoantibodies
Aggrecanb 0.0 (0.0, 30.8) 148.5 (1.2, 519.3) 0.006
Amyloidb 45.8 (0.0, 106.9) 13.6 (1.1, 106.9) 0.843
CENP-Bb 3,659.3 (2,152.0, 6,249.1) 4,134.9 (2,908.3, 12,490.8) 0.325
Collagen Ib 283.6 (95.6, 365.7) 199.1 (93.6, 383.1) 0.941
Collagen IIb 463.9 (0.0, 1,252.4) 463.3 (109.0, 1,221.0) 0.336
Collagen IVb 1.2 (0.0, 321.8) 20.8 (1.1, 307.6) 0.359
Cytochrome Ca 11,815.6 (9,060.0, 14,571.2) 8,710.0 (265.4, 791.2) 0.036
Cytokeratin 18b 3,926.2 (1,233.7, 6,578.3) 4,046.7 (845.2, 12,122.9) 0.863
Elastina 10,719.3 (8,817.8, 12,620.8) 9,769.0 (8,409.5, 11,128.6) 0.396
HSP47b 232.2 (117.3, 930.8) 416.4 (127.0, 782.3) 0.806
HSP70b 5,364.2 (3,779.5, 7,710.8) 6,418.4 (4,536.1, 7,907.4) 0.572
SS-Bb 5,831.1 (4,664.5, 10,809.2) 5,000.8 (4,604.1, 6,589.2) 0.446
Vimentinb 677.7 (504.5, 1,471.3) 512.3 (278.7, 835.2) 0.268
Sputum cell counts
Neutrophils (%)a 53.3 (39.3, 67.3) 77.4 (70.7, 84.2) 0.001
Macrophages (%)b 51.2 (30.2, 58.0) 15.1 (4.6, 23.9) 0.001
Eosinophils (%)a 1.6 (0.7, 2.5) 3.6 (2.5, 4.7) 0.004
Lymphocytes (%)b 1.4 (1.1, 2.0) 0.9 (0.4, 1.7) 0.249

Notes:

a

Data with normal distribution were expressed as mean and 95% CI and analyzed by t-test.

b

Data with non-normal distribution were expressed as median and interquartile range (IQR) and analyzed by Mann–Whitney U test.

Abbreviations: CENP-B, centromere protein B; HSP70, heat shock protein 70; IL, interleukin; INF-γ, interferon-γ; sRAGE, the soluble receptor for advanced glycation end-products; SS-B, La/Sjögren syndrome type B antigen; TNFα, tumor necrosis factor-α; VEGF, vascular endothelial growth factor.